After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Olema Pharmaceuticals Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Olema Pharmaceuticals Inc is $608.66M. A total of 0.61 million shares were traded on the day, compared to an average of 502.52K shares.
In the most recent transaction, Paradigm Biocapital Advisors L sold 2,400,000 shares of OLMA for 14.91 per share on Aug 01 ’24. After the transaction, the 10% Owner now owns 783,118 company shares. In a previous transaction on Jul 29 ’24, Harmon Cyrus sold 4,066 shares at 15.58 per share. OLMA shares that Director owns now total 752,217.
Among the insiders who sold shares, Harmon Cyrus disposed of 934 shares on Jul 30 ’24 at a per-share price of $15.55. This resulted in the Director holding 751,283 shares of OLMA after the transaction. In another insider transaction, Harmon Cyrus bought 934 shares at $15.55 per share on Jul 30 ’24.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, OLMA has a high of $16.77 and a low of $7.68.
As of this writing, OLMA has an earnings estimate of $0.15 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of $4.23 per share and a lower estimate of -$0.7. The company reported an EPS of -$0.49 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. OLMA’s latest balance sheet shows that the firm has $287.25M in Cash & Short Term Investments as of fiscal 2021. There were $3.29M in debt and $9.02M in liabilities at the time. Its Book Value Per Share was $3.47, while its Total Shareholder’s Equity was $284.57M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for OLMA is Buy with a score of 5.00.
